Show simple item record

dc.contributor.authorPrugger, Christof
dc.contributor.authorSpelsberg, Angela
dc.contributor.authorKeil, Ulrich
dc.contributor.authorErviti, Juan
dc.contributor.authorDoshi, Peter
dc.date.accessioned2021-12-28T13:02:43Z
dc.date.available2021-12-28T13:02:43Z
dc.date.issued2021-12-23
dc.identifier.urihttp://hdl.handle.net/10713/17450
dc.description.urihttps://doi.org/10.1136/bmj-2021-067570en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofBMJen_US
dc.subject.meshCOVID-19 Vaccinesen_US
dc.titleEvaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.en_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj-2021-067570
dc.identifier.pmid34949587
dc.source.journaltitleBMJ (Clinical research ed.)
dc.source.volume375
dc.source.beginpagee067570
dc.source.endpage
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record